- Home
- RMTI vs BNR Comparison
RMTI vs BNR Comparison
Compare RMTI & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- BNR
- Stock Information
- Founded
- RMTI 1994
- BNR 2014
- Country
- RMTI United States
- BNR China
- Employees
- RMTI N/A
- BNR N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- BNR Medical Specialities
- Sector
- RMTI Health Care
- BNR Health Care
- Exchange
- RMTI Nasdaq
- BNR Nasdaq
- Market Cap
- RMTI 32.5M
- BNR 38.3M
- IPO Year
- RMTI 1998
- BNR 2020
- Fundamental
- Price
- RMTI $1.11
- BNR $4.59
- Analyst Decision
- RMTI Strong Buy
- BNR
- Analyst Count
- RMTI 2
- BNR 0
- Target Price
- RMTI $4.00
- BNR N/A
- AVG Volume (30 Days)
- RMTI 459.4K
- BNR 16.9K
- Earning Date
- RMTI 08-14-2025
- BNR 08-21-2025
- Dividend Yield
- RMTI N/A
- BNR N/A
- EPS Growth
- RMTI N/A
- BNR N/A
- EPS
- RMTI N/A
- BNR N/A
- Revenue
- RMTI $97,727,000.00
- BNR $72,112,038.00
- Revenue This Year
- RMTI N/A
- BNR $136.32
- Revenue Next Year
- RMTI $11.16
- BNR N/A
- P/E Ratio
- RMTI N/A
- BNR N/A
- Revenue Growth
- RMTI 12.82
- BNR 0.53
- 52 Week Low
- RMTI $0.78
- BNR $2.18
- 52 Week High
- RMTI $5.15
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- RMTI 56.21
- BNR 68.34
- Support Level
- RMTI $0.80
- BNR $4.47
- Resistance Level
- RMTI $1.13
- BNR $4.96
- Average True Range (ATR)
- RMTI 0.10
- BNR 0.27
- MACD
- RMTI 0.03
- BNR 0.12
- Stochastic Oscillator
- RMTI 45.37
- BNR 80.53
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.